PARP-1-IN-23

PARP-1-IN-23 (Compound I16) is a potent and selective PARP-1 inhibitor with an IC50 of 12.38 nM, demonstrating oral bioavailability. It is a valuable research tool for investigating DNA damage response pathways and has shown efficacy in suppressing tumor growth in preclinical in vivo models.